APA (7th ed.) Citation

JP, N., C, S., D, Ö., P, H., & DH, P. (2026). Clinical implications and biomarkers in the PACT-21 CASSANDRA trial. Lancet (London, England), 407(10540), 1684. https://doi.org/10.1016/S0140-6736(26)00641-0

Chicago Style (17th ed.) Citation

JP, Neoptolemos, Springfeld C, Öhlund D, Hammel P, and Palmer DH. "Clinical Implications and Biomarkers in the PACT-21 CASSANDRA Trial." Lancet (London, England) 407, no. 10540 (2026): 1684. https://doi.org/10.1016/S0140-6736(26)00641-0.

MLA (9th ed.) Citation

JP, Neoptolemos, et al. "Clinical Implications and Biomarkers in the PACT-21 CASSANDRA Trial." Lancet (London, England), vol. 407, no. 10540, 2026, p. 1684, https://doi.org/10.1016/S0140-6736(26)00641-0.